News Formal

Danaher to Buy Abcam in $5.7 Billion Deal. Investors Don’t Like the Premium.

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 97%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

The industrial scientific-supplies company agrees to acquire all shares outstanding for $24.00 each.

Danaher announced on Monday that it agreed to acquire biotech company Abcam in a deal valued at $5.7 billion.

It appeared that Abcam investors weren’t pleased with the premium. American depositary receipts of Abcam were dropping 3% in the premarket session. Shares of Danaher were flat in premarket trading Monday to $255.53.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

BYD Electronic plans to buy Jabil manufacturing subsidiary for nearly $2.2 billionBYD Electronic is planning to buy a company that could own a manufacturing business in the Chinese cities of Chengdu and Wuxi for nearly $2.2 billion to...
Source: MarketWatch - 🏆 3. / 97 Read more »